(19)
(11) EP 3 331 556 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.02.2019 Bulletin 2019/09

(45) Mention of the grant of the patent:
31.10.2018 Bulletin 2018/44

(21) Application number: 16809888.7

(22) Date of filing: 16.12.2016
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
C07H 15/04(2006.01)
 A61K 31/70(2006.01)
C07K 16/00(2006.01)
(86) International application number:
PCT/EP2016/081586
(87) International publication number:
WO 2017/103211 (22.06.2017 Gazette 2017/25)

(54)

SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 2

SYNTHETISCHE IMPFSTOFFE GEGEN STREPTOCOCCUS PNEUMONIAE-SEROTYP 2

VACCINS CONTRE LE STREPTOCOCCUS PNEUMONIAE DE SÉROTYPE 2

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.12.2015 EP 15200729
28.04.2016 EP 16167505

(43) Date of publication of application:
13.06.2018 Bulletin 2018/24

(73) Proprietor: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
80539 München (DE)

(72) Inventors:
  • SEEBERGER, Peter H.
    14532 Kleinmachnow (DE)
  • PEREIRA, Claney Lebev
    12203 Berlin (DE)
  • ANISH, Chakkumkal
    2592 AR Den Haag (NL)
  • KHAN, Naeem
    Kalamazoo 49007, Michigan (US)
  • EMMADI, Madhu
    12167 Berlin (DE)

(74) Representative: Arth, Hans-Lothar 
ABK Patent Attorneys Jasminweg 9
14052 Berlin
14052 Berlin (DE)


(56) References cited: : 
WO-A2-2007/116028
 WO-A2-2014/097099
   
  • POZSGAY VINCE: "Recent developments in synthetic oligosaccharide-based bacterial vaccines", CURRENT TOPICS IN MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS LTD, HILVERSUM; NL, vol. 8, no. 2, 1 January 2008 (2008-01-01) , pages 126-140, XP002552158, ISSN: 1568-0266, DOI: 10.2174/156802608783378864
  • JOOSTEN J A F ET AL: "Chemo-enzymatic synthesis of tetra-, penta-, and hexasaccharide fragments of the capsular polysaccharide of Streptococcus pneumoniae type 14", CARBOHYDRATE RESEARCH, PERGAMON, GB, vol. 338, no. 23, 14 November 2003 (2003-11-14), pages 2629-2651, XP004479533, ISSN: 0008-6215, DOI: 10.1016/S0008-6215(03)00292-1
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).